{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:53:16Z","timestamp":1781632396149,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["NCN 2016\/22\/E\/NZ4\/00665"],"award-info":[{"award-number":["NCN 2016\/22\/E\/NZ4\/00665"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to elucidate the mystery of \u201cdisappearing\u201d oleic acid (OA) in colorectal cancer (CRC) cells. The primary objective was to verify if OA is predominantly used as an energy source or as a substrate for the synthesis of other molecules, given the paradox of elevated stearoyl-CoA desaturase-1 (SCD1) expression and lower OA levels in CRC tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Tissue samples from CRC patients were analyzed for fatty acid (FA) profiles (GC-MS) and SCD1 mRNA levels (real-time PCR). For in-vitro experiments, CRC cell lines (HT-29, WiDr) and a normal human colon cell line (CCD-881-CoN) were incubated with either\n                      <jats:sup>13<\/jats:sup>\n                      C-stearic acid (SA) or\n                      <jats:sup>3<\/jats:sup>\n                      H-OA. GC-MS was employed to track\n                      <jats:sup>13<\/jats:sup>\n                      C-labeled FA conversions, whereas thin-layer chromatography (TLC) followed by radioactivity measurement for\n                      <jats:sup>3<\/jats:sup>\n                      H-labeled metabolites was utilized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Tracking\n                      <jats:sup>13<\/jats:sup>\n                      C-SA metabolism revealed its conversion to\n                      <jats:sup>13<\/jats:sup>\n                      C-OA but also a significant \u201cdisappearance\u201d of its metabolites from the FA pool. Experiments with\n                      <jats:sup>3<\/jats:sup>\n                      H-OA showed that free cholesterol (FCH) was the most abundant molecule originating from\n                      <jats:sup>3<\/jats:sup>\n                      H-OA (67\u201377% of redirected tritium) in CRC cells, indicating its major metabolic fate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides strong evidence that in CRC cells, despite SCD1 overexpression, a significant amounts of OA are converted to FCH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12935-026-04190-w","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:14:07Z","timestamp":1769274847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cResolving the SCD1-oleic acid paradox: majority of oleic acid is converted to free cholesterol in colorectal cancer cells\u201d"],"prefix":"10.1186","volume":"26","author":[{"given":"Aleksandra","family":"Czumaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Kobiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Sledzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"4190_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z.","journal-title":"Br J Cancer"},{"key":"4190_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1032806","author":"M Hoxha","year":"2022","unstructured":"Hoxha M, Zappacosta B. A review on the role of fatty acids in colorectal cancer progression. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.1032806.","journal-title":"Front Pharmacol"},{"key":"4190_CR3","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2801010","volume":"28","author":"Q He","year":"2023","unstructured":"He Q, Chen Y, Wang Z, He H, Yu P. Cellular uptake, metabolism and sensing of long-chain fatty acids. Front Biosci Landmark. 2023;28:10.","journal-title":"Front Biosci Landmark"},{"key":"4190_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/J.PLEFA.2007.05.003","volume":"76","author":"P Ris\u00e9","year":"2007","unstructured":"Ris\u00e9 P, Eligini S, Ghezzi S, Colli S, Galli C. Fatty acid composition of plasma, blood cells and whole blood: relevance for the assessment of the fatty acid status in humans. Prostaglandins Leukot Essent Fat Acids. 2007;76:363\u20139. https:\/\/doi.org\/10.1016\/J.PLEFA.2007.05.003.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"4190_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116195","volume":"10","author":"SA Abdelmagid","year":"2015","unstructured":"Abdelmagid SA, Clarke SE, Nielsen DE, Badawi A, El-Sohemy A, Mutch DM, et al. Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults. PLoS One. 2015;10:e0116195. https:\/\/doi.org\/10.1371\/journal.pone.0116195.","journal-title":"PLoS One"},{"key":"4190_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1159\/000458431","volume":"41","author":"A Mika","year":"2017","unstructured":"Mika A, Kobiela J, Czumaj A, Chmielewski M, Stepnowski P, Sledzinski T. Hyper-elongation in colorectal cancer tissue - cerotic acid is a potential novel serum metabolic marker of colorectal malignancies. Cell Physiol Biochem. 2017;41:722\u201330. https:\/\/doi.org\/10.1159\/000458431.","journal-title":"Cell Physiol Biochem"},{"key":"4190_CR7","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/BJC.1998.328","volume":"77","author":"L Bar\u00f3","year":"1998","unstructured":"Bar\u00f3 L, Hermoso JC, N\u00fa\u00f1ez MC, Jim\u00e9nez-Rios JA, Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer. 1998;77:1978\u201383. https:\/\/doi.org\/10.1038\/BJC.1998.328.","journal-title":"Br J Cancer"},{"key":"4190_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/BJC.1988.262","volume":"58","author":"JP Neoptolemos","year":"1988","unstructured":"Neoptolemos JP, Clayton H, Heagerty AM, Nicholson MJ, Johnson B, Mason J, Manson K, James L, Bell RF;F. Dietary fat in relation to fatty acid composition of red cells and adipose tissue in colorectal cancer. Br J Cancer. 1988;58:575\u20139. https:\/\/doi.org\/10.1038\/BJC.1988.262.","journal-title":"Br J Cancer"},{"key":"4190_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41698-017-0040-z","volume":"1","author":"LM Butler","year":"2017","unstructured":"Butler LM, Yuan J-M, Huang JY, Su J, Wang R, Koh W-P, et al. Plasma fatty acids and risk of colon and rectal cancers in the Singapore Chinese health study. NPJ Precis Oncol. 2017;1:1\u20139. https:\/\/doi.org\/10.1038\/s41698-017-0040-z.","journal-title":"NPJ Precis Oncol"},{"key":"4190_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.plefa.2013.02.005","volume":"88","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang L, Ye X, Chen L, Zhang L, Gao Y, et al. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. Prostaglandins Leukot Essent Fatty Acids. 2013;88:355\u201360. https:\/\/doi.org\/10.1016\/j.plefa.2013.02.005.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4190_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9041095","volume":"9","author":"A Mika","year":"2020","unstructured":"Mika A, Pakiet A, Czumaj A, Kaczynski Z, Liakh I. Decreased triacylglycerol content and elevated contents of cell membrane lipids in colorectal cancer tissue: a lipidomic study. J Clin Med. 2020;9:1\u201311.","journal-title":"J Clin Med"},{"key":"4190_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-018-0711-9\/FIGURES\/8","volume":"37","author":"H Ran","year":"2018","unstructured":"Ran H, Zhu Y, Deng R, Zhang Q, Liu X, Feng M, et al. Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. J Exp Clin Cancer Res. 2018;37:1\u201315. https:\/\/doi.org\/10.1186\/S13046-018-0711-9\/FIGURES\/8.","journal-title":"J Exp Clin Cancer Res"},{"key":"4190_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.689701","volume":"11","author":"A Mika","year":"2021","unstructured":"Mika A, Duzowska K, Halinski LP, Pakiet A, Czumaj A, Rostkowska O, et al. Rearrangements of blood and tissue fatty acid profile in colorectal cancer - molecular mechanism and diagnostic potential. Front Oncol. 2021;11:1\u201312. https:\/\/doi.org\/10.3389\/fonc.2021.689701.","journal-title":"Front Oncol"},{"key":"4190_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22179507","author":"A Kubicka","year":"2021","unstructured":"Kubicka A, Matczak K, \u0141abieniec-Wata\u0142a M. More than meets the eye regarding cancer metabolism. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/IJMS22179507.","journal-title":"Int J Mol Sci"},{"key":"4190_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.CMET.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320. https:\/\/doi.org\/10.1016\/J.CMET.2007.10.002.","journal-title":"Cell Metab"},{"key":"4190_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"4190_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58895-7","volume":"10","author":"A Mika","year":"2020","unstructured":"Mika A, Kobiela J, Pakiet A, Czumaj A, Soko\u0142owska E, Makarewicz W, et al. Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells. Sci Rep. 2020;10:1954.","journal-title":"Sci Rep"},{"key":"4190_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS26094015","volume":"26","author":"HH Jarullah","year":"2025","unstructured":"Jarullah HH, Saleh ES. Influence of fatty acid desaturase enzyme-1 gene (FADS-1) polymorphism on serum polyunsaturated fatty acids levels, desaturase enzymes, lipid profile, and glycemic control parameters in newly diagnosed diabetic mellitus patients. Int J Mol Sci. 2025;26:4015. https:\/\/doi.org\/10.3390\/IJMS26094015.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4190_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391. https:\/\/doi.org\/10.3758\/BF03193146.","journal-title":"Behav Res Methods"},{"key":"4190_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/IJMS26031186\/S1","volume":"26","author":"J Zabielska","year":"2025","unstructured":"Zabielska J, Stelmanska E, Szrok-Jurga S, Kobiela J, Czumaj A. Lipids metabolism Inhibition antiproliferative synergy with 5-Fluorouracil in human colorectal cancer model. Int J Mol Sci. 2025;26:1186. https:\/\/doi.org\/10.3390\/IJMS26031186\/S1.","journal-title":"Int J Mol Sci"},{"key":"4190_CR21","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.7150\/THNO.85855","volume":"13","author":"CJ Shen","year":"2023","unstructured":"Shen CJ, Chan RH, Lin BW, Li NC, Huang YH, Chang WC, Chen BK. Oleic acid-induced metastasis of KRAS\/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation. Theranostics. 2023;13:4650. https:\/\/doi.org\/10.7150\/THNO.85855.","journal-title":"Theranostics"},{"key":"4190_CR22","doi-asserted-by":"publisher","unstructured":"Chen Y, Zhong Z, Ruan X, Zhan X, Ding Y, Wei F, Qin X, Yu H, Lu Y. Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1. Dig Liver Dis. 2024;57. https:\/\/doi.org\/10.1016\/j.dld.2024.11.008.","DOI":"10.1016\/j.dld.2024.11.008"},{"key":"4190_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/S13048-024-01389-1","author":"J Lee","year":"2024","unstructured":"Lee J, Jang S, Im J, Han Y, Kim S, Jo HA, et al. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells. J Ovarian Res. 2024. https:\/\/doi.org\/10.1186\/S13048-024-01389-1.","journal-title":"J Ovarian Res"},{"key":"4190_CR24","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1158\/2767-9764.CRC-23-0138","volume":"3","author":"K Katoh","year":"2023","unstructured":"Katoh K, Katoh Y, Kubo A, Iida M, Ikeda Y, Iwata T, et al. Serum free fatty acid changes caused by high expression of stearoyl-CoA desaturase 1 in tumor tissues are early diagnostic markers for ovarian cancer. Cancer Res Commun. 2023;3:1840\u201352. https:\/\/doi.org\/10.1158\/2767-9764.CRC-23-0138.","journal-title":"Cancer Res Commun"},{"key":"4190_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0229864","author":"E Gharib","year":"2020","unstructured":"Gharib E, Nasrinasrabadi P, Zali MR. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer. PLoS One. 2020. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0229864.","journal-title":"PLoS One"},{"key":"4190_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/S11010-018-3306-Z\/FIGURES\/5","volume":"447","author":"M Presler","year":"2018","unstructured":"Presler M, Wojtczyk-Miaskowska A, Schlichtholz B, Kaluzny A, Matuszewski M, Mika A, Sledzinski T, Swierczynski J. Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer. Mol Cell Biochem. 2018;447:217\u201324. https:\/\/doi.org\/10.1007\/S11010-018-3306-Z\/FIGURES\/5.","journal-title":"Mol Cell Biochem"},{"key":"4190_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115665240369037250319000043","volume":"25","author":"M Li","year":"2025","unstructured":"Li M, Yue M, Chen Y, Zhao G. High glycolysis and lipid metabolism status predicts poor prognosis in colorectal cancer patients. Curr Mol Med. 2025;25:1\u201314. https:\/\/doi.org\/10.2174\/0115665240369037250319000043.","journal-title":"Curr Mol Med"},{"key":"4190_CR28","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/JCP.31137","volume":"238","author":"Z Tracz-Gaszewska","year":"2023","unstructured":"Tracz-Gaszewska Z, Sowka A, Dobrzyn P. Stearoyl-CoA desaturase 1 inhibition impairs triacylglycerol accumulation and lipid droplet formation in colorectal cancer cells. J Cell Physiol. 2023;238:2888\u2013903. https:\/\/doi.org\/10.1002\/JCP.31137.","journal-title":"J Cell Physiol"},{"key":"4190_CR29","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.7150\/IJBS.68484","volume":"18","author":"S Peng","year":"2022","unstructured":"Peng S, Li Y, Huang M, Tang G, Xie Y, Chen D, et al. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022;18:1912\u201332. https:\/\/doi.org\/10.7150\/IJBS.68484.","journal-title":"Int J Biol Sci"},{"key":"4190_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/JCM9041095","volume":"9","author":"A Mika","year":"2020","unstructured":"Mika A, Pakiet A, Czumaj A, Kaczynski Z, Liakh I, Kobiela J, et al. Decreased triacylglycerol content and elevated contents of cell membrane lipids in colorectal cancer tissue: a lipidomic study. J Clin Med 2020, Vol 9, Page 1095. 2020;9:1095. https:\/\/doi.org\/10.3390\/JCM9041095.","journal-title":"J. Clin. Med. 2020, Vol. 9, Page 1095"},{"key":"4190_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/SREP20790","volume":"6","author":"Y Tian","year":"2016","unstructured":"Tian Y, Xu T, Huang J, Zhang L, Xu S, Xiong B, Wang Y, Tang H. Tissue metabonomic phenotyping for diagnosis and prognosis of human colorectal cancer. Sci Rep. 2016;6:1\u201310. https:\/\/doi.org\/10.1038\/SREP20790. TECHMETA=141;SUBJMETA=1857,2327,631,67,692,699;KWRD=CANCER+METABOLISM,TUMOUR+BIOMARKERS.","journal-title":"Sci Rep"},{"key":"4190_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01512-x","volume":"20","author":"A Pakiet","year":"2021","unstructured":"Pakiet A, Sikora K, Kobiela J, Rostkowska O, Mika A, Sledzinski T. Alterations in complex lipids in tumor tissue of patients with colorectal cancer. Lipids Health Dis. 2021;20:85. https:\/\/doi.org\/10.1186\/s12944-021-01512-x.","journal-title":"Lipids Health Dis"},{"key":"4190_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/S11033-025-10472-9","author":"A Karimpur-Zahmatkesh","year":"2025","unstructured":"Karimpur-Zahmatkesh A, Khalaj-Kondori M. The perspective of targeting cancer cell metabolism: combination therapy approaches. Mol Biol Rep. 2025. https:\/\/doi.org\/10.1007\/S11033-025-10472-9.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"4190_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES13010210","volume":"13","author":"Z Liang","year":"2025","unstructured":"Liang Z, Deng L, Zhou X, Zhang Z, Zhao W. Comprehensive overview of ketone bodies in cancer metabolism: mechanisms and application. Biomedicines. 2025;13(1):210. https:\/\/doi.org\/10.3390\/BIOMEDICINES13010210.","journal-title":"Biomedicines"},{"key":"4190_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.TRANON.2021.101043","volume":"14","author":"SS Mayengbam","year":"2021","unstructured":"Mayengbam SS, Singh A, Pillai AD, Bhat MK. Influence of cholesterol on cancer progression and therapy. Transl Oncol. 2021;14:101043. https:\/\/doi.org\/10.1016\/J.TRANON.2021.101043.","journal-title":"Transl Oncol"},{"key":"4190_CR36","first-page":"219","volume":"9","author":"X Ding","year":"2019","unstructured":"Ding X, Zhang W, Li S, Yang H. The role of cholesterol metabolism in cancer. Am J Cancer Res. 2019;9:219.","journal-title":"Am J Cancer Res"},{"key":"4190_CR37","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.7150\/IJBS.92274","volume":"20","author":"W Jiang","year":"2024","unstructured":"Jiang W, Jin WL, Xu AM. Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities. Int J Biol Sci. 2024;20:2044\u201371. https:\/\/doi.org\/10.7150\/IJBS.92274.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"4190_CR38","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","volume":"55","author":"M Xiao","year":"2023","unstructured":"Xiao M, Xu J, Wang W, Zhang B, Liu J, Li J, et al. Functional significance of cholesterol metabolism in cancer: from threat to treatment. Exp Mol Med. 2023;55(9):1982\u201395. https:\/\/doi.org\/10.1038\/s12276-023-01079-w.","journal-title":"Exp Mol Med"},{"key":"4190_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2021.622908\/FULL","volume":"9","author":"R Vona","year":"2021","unstructured":"Vona R, Iessi E, Matarrese P. Role of cholesterol and lipid rafts in cancer signaling: a promising therapeutic opportunity? Front Cell Dev Biol. 2021;9:622908. https:\/\/doi.org\/10.3389\/FCELL.2021.622908\/FULL.","journal-title":"Front Cell Dev Biol"},{"key":"4190_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2025.1579054\/FULL","volume":"15","author":"FA Lagunas-Rangel","year":"2025","unstructured":"Lagunas-Rangel FA. Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications. Front Oncol. 2025;15:1579054. https:\/\/doi.org\/10.3389\/FONC.2025.1579054\/FULL.","journal-title":"Front Oncol"},{"key":"4190_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/IJMM.2025.5667\/HTML","volume":"56","author":"Z He","year":"2025","unstructured":"He Z, Zhang L, Gong S, Yang X, Xu G. Cholesterol metabolism and cancer: molecular mechanisms, immune regulation and an epidemiological perspective (Review). Int J Mol Med. 2025;56:1\u201322. https:\/\/doi.org\/10.3892\/IJMM.2025.5667\/HTML.","journal-title":"Int J Mol Med"},{"key":"4190_CR42","doi-asserted-by":"publisher","first-page":"35541","DOI":"10.18632\/oncotarget.26222","volume":"9","author":"A Sorvina","year":"2018","unstructured":"Sorvina A, Bader CA, Caporale C, Carter EA, Johnson IRD, Parkinson-Lawrence EJ, et al. Lipid profiles of prostate cancer cells. Oncotarget. 2018;9:35541\u201352. https:\/\/doi.org\/10.18632\/oncotarget.26222.","journal-title":"Oncotarget"},{"key":"4190_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2297-3","volume":"2020 112","author":"ALS Cruz","year":"2020","unstructured":"Cruz ALS, Barreto E, de Fazolini A, Viola NPB, Bozza JPB. Lipid droplets: platforms with multiple functions in cancer hallmarks. Cell Death Dis. 2020;2020 112:1\u201316. https:\/\/doi.org\/10.1038\/s41419-020-2297-3.","journal-title":"Cell Death Dis"},{"key":"4190_CR44","doi-asserted-by":"publisher","first-page":"167576","DOI":"10.1016\/J.BBADIS.2024.167576","volume":"1871","author":"C Margherita","year":"2025","unstructured":"Margherita C, Elizabeta I, Stefania M, Giuliano B, Sofia A, Nicola B. Uncovering the protective role of lipid droplet accumulation against acid-induced oxidative stress and cell death in osteosarcoma. Biochim Biophys Acta - Mol Basis Dis. 2025;1871:167576. https:\/\/doi.org\/10.1016\/J.BBADIS.2024.167576.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"4190_CR45","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/cas.12221","volume":"104","author":"N Kurabe","year":"2013","unstructured":"Kurabe N, Hayasaka T, Ogawa M, Masaki N, Ide Y, Waki M, et al. Accumulated phosphatidylcholine (16:0\/16:1) in human colorectal cancer; possible involvement of LPCAT4. Cancer Sci. 2013;104:1295\u2013302. https:\/\/doi.org\/10.1111\/cas.12221.","journal-title":"Cancer Sci"},{"key":"4190_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.768606","volume":"13","author":"R Saito","year":"2022","unstructured":"Saito R, de Andrade F, de Bustos LN, Chammas SO. Phosphatidylcholine-Derived lipid mediators: the crosstalk between cancer cells and immune cells. Front Immunol. 2022;13:1\u201324. https:\/\/doi.org\/10.3389\/fimmu.2022.768606.","journal-title":"Front Immunol"},{"key":"4190_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3162","volume":"11","author":"K Glunde","year":"2011","unstructured":"Glunde K, Bhujwalla ZM, Ronen SM. Choline metabolism in malignant transformation. Nat Rev Cancer. 2011;11:835\u201348. https:\/\/doi.org\/10.1038\/nrc3162.","journal-title":"Nat Rev Cancer"},{"key":"4190_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2019.158579","volume":"1865","author":"Y Wang","year":"2020","unstructured":"Wang Y, Hinz S, Uckermann O, H\u00f6nscheid P, von Sch\u00f6nfels W, Burmeister G, et al. Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2020;1865:158579. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158579.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"4190_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02732-5","volume":"9","author":"AK Cotte","year":"2018","unstructured":"Cotte AK, Aires V, Fredon M, Limagne E, Derang\u00e8re V, Thibaudin M, et al. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. Nat Commun. 2018;9:322. https:\/\/doi.org\/10.1038\/s41467-017-02732-5.","journal-title":"Nat Commun"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04190-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04190-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:06:40Z","timestamp":1781629600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04190-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4190"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04190-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation was carried out in accordance with the World Medical Association Declaration of Helsinki and the Medical University of Gdansk Ethics Committee approved the study protocol (no. NKBN\/487\/2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written and informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}